INS and type 2 diabetes mellitus: In addition, patients treated with semaglutide experienced a significant de-intensification of T2D treatment, with reductions in the number of daily glucose-lowering drugs, basal insulin doses, and proportion of patients with insulin therapy, with a good tolerability profile.